Francis Farhadi
8
6
7
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
100%
1 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Degenerative Cervical Myelopathy Repository
Role: lead
Prospective Analysis of Spinal Epidural Abscess
Role: lead
Spinal Cord Injury Neuroprotection With Glyburide
Role: lead
Lumbar Fusion With Porous Versus Non-Porous Cages
Role: lead
Spinal Decompression Plus Nerve Graft Implantation Following TSCI
Role: lead
Thoracic-Lumbar Arthrodesis- Implanet Jazz
Role: lead
MMG vs. EMG for Cortical Breach Detection
Role: lead
Evaluating Safety and Feasibility of Transcutaneous Spinal Cord Stimulation Following Traumatic and Non-Traumatic Spinal Cord Injury: A Pilot Study
Role: lead
All 8 trials loaded